Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 393-398

  Hing, Sandra ^a   Lu, Yong Jie ^a   Summersgill, Brenda ^a   King Underwood, Linda ^a   Nicholson, James ^a   Grundy, Paul ^c   Grundy, Richard ^b   Gessler, Manfred ^d   Shipley, Janet ^a   Pritchard Jones, Kathy ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c CROSS CANCER INSTITUTE   (Canada)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 1Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; GENE LOCUS; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; PRIORITY JOURNAL; RELAPSE; TUMOR SUPPRESSOR GENE;

EID: 0035135573     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63982-X     Document Type: Article

References (23)

1. Response rates in relapsed Wilms' tumor
2. Clonal expansion attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations
3. The genetics of Wilms' tumour - A case of disrupted development
4. Germline somatic abnormalities of chromosome 7 in Wilms' tumour
5. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21
6. Linkage of familial Wilms' tumour predisposition to chromosome 19 and a two-locus model for the etiology of familial tumours
7. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance
8. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumours predicts an adverse outcome
9. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour
10. Allele loss in Wilms' tumors of chromosome arms 11q, 16q and 22q correlates with clinicopathological parameters
11. Expression of multidrug resistance gene in human cancers
12. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome
13. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor
14. Gains, losses and amplification of genomic material in rhabdomyosarcoma analysed by comparative genomic hybridisation
15. 1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment
16. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
17. Comparative genomic hybridization its application to Wilms' tumorigenesis
18. Comparative genomic hybridization analysis of Wilms' tumours
19. Cytogenetics molecular genetics of Wilms' tumor of childhood
20. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
21. Molecular characterization of a novel amplicon at 1q21-1q22 frequently observed in human sarcomas
22. Allelic imbalance at chromosome 1q21 in Wilms' tumor